NATURECOMMUNICATIONS|DOI:10.1038/ncomms7235
ARTICLE
43.Cao,J.M.etal.Relationshipbetweenregionalcardiachyperinnervationandventriculararrhythmia.Circulation101,1960–1969(2000).
44.Zhou,S.etal.Mechanismsofcardiacnervesproutingaftermyocardialinfarctionindogs.Circ.Res.95,76–83(2004).
45.Hasan,W.etal.Sympathetichyperinnervationandin ammatorycellNGFsynthesisfollowingmyocardialinfarctioninrats.BrainRes.1124,142–154(2006).
46.Oh,Y.S.etal.Spatialdistributionofnervesproutingaftermyocardialinfarctioninmice.HeartRhythm3,728–736(2006).
47.Moss,A.J.etal.Prophylacticimplantationofade brillatorinpatients
withmyocardialinfarctionandreducedejectionfraction.N.Engl.J.Med.346,877–883(2002).
48.Goldenberg,I.etal.Long-termbene tofprimarypreventionwithan
implantablecardioverter-de brillator:AnExtended8-YearFollow-UpStudyoftheMulticenterAutomaticDe brillatorImplantationTrialII.Circulation122,1265–1271(2010).
49.Nerbonne,J.M.Mousemodelsofarrhythmogeniccardiovasculardisease:challengesandopportunities.Curr.Opin.Pharmacol.15,107–114(2014).50.Jouven,X.etal.Heart-ratepro leduringexerciseasapredictorofsuddendeath.N.Engl.J.Med.352,1951–1958(2005).
51.Elchebly,M.etal.Neuroendocrinedysplasiainmicelackingproteintyrosinephosphatasesigma.Nat.Genet.21,330–333(1999).
52.Faggioni,M.etal.Acceleratedsinusrhythmpreventscatecholaminergicpolymorphicventriculartachycardiainmiceandinpatients.Circ.Res.112,689–697(2013).
53.Nebel,M.etal.Nicotinicacidadeninedinucleotidephosphate(NAADP)-mediatedcalciumsignalingandarrhythmiasintheheartevokedbyb-adrenergicstimulation.J.Biol.Chem.288,16017–16030(2013).
54.Bayly,P.V.etal.Estimationofconductionvelocityvector eldsfromepicardialmappingdata.IEEETrans.Biomed.Eng.45,563–571(1998).
55.Verrier,R.L.etal.MicrovoltT-wavealternansphysiologicalbasis,methodsofmeasurement,andclinicalutility--consensusguidelinebyInternationalSocietyforHolterandNoninvasiveElectrocardiology.J.Am.Coll.Cardiol.58,1309–1324(2011).
56.Myles,R.C.,Burton,F.L.,Cobbe,S.M.&Smith,G.L.Alternansofactionpotentialdurationandamplitudeinrabbitswithleftventriculardysfunctionfollowingmyocardialinfarction.J.Mol.CellCardiol.50,510–521(2011).57.Wang,L.etal.OpticalmappingofsarcoplasmicreticulumCa2þinthe
intactheart:ryanodinereceptorrefractorinessduringalternansand brillation.Circ.Res.114,1410–1421(2014).
15.Simula,S.etal.Cardiacadrenergicinnervationwithinthe rst3monthsafteracutemyocardialinfarction.Clin.Physiol.20,366–373(2000).
16.Stanton,M.S.etal.RegionalsympatheticdenervationaftermyocardialinfarctioninhumansdetectednoninvasivelyusingI-123-metaiodobenzylguanidine.J.Am.Coll.Cardiol.14,1519–1526(1989).17.Barber,M.J.,Mueller,T.M.,Henry,D.P.,Felten,S.Y.&Zipes,D.P.Transmuralmyocardialinfarctioninthedogproducessympathectomyinnoninfarctedmyocardium.Circulation67,787–796(1983).
18.Boogers,M.J.etal.Cardiacsympatheticdenervationassessedwith123-iodinemetaiodobenzylguanidineimagingpredictsventriculararrhythmiasinimplantablecardioverter-de brillatorpatients.J.Am.Coll.Cardiol.55,2769–2777(2010).
19.Nishisato,K.etal.Impairedcardiacsympatheticinnervationandmyocardialperfusionarerelatedtolethalarrhythmia:quanti cationofcardiactracersinpatientswithICDs.J.Nucl.Med.51,1241–1249(2010).
20.Fallavollita,J.A.etal.Regionalmyocardialsympatheticdenervationpredictstheriskofsuddencardiacarrestinischemiccardiomyopathy.J.Am.Coll.Cardiol.63,141–149(2014).
21.Vaseghi,M.,Lux,R.L.,Mahajan,A.&Shivkumar,K.Sympatheticstimulationincreasesdispersionofrepolarizationinhumanswithmyocardialinfarction.Am.J.Physiol.HeartCirc.Physiol.302,H1838–H1846(2012).
22.Rubart,M.&Zipes,D.P.Mechanismsofsuddencardiacdeath.J.Clin.Invest.115,2305–2315(2005).
23.Gardner,R.T.&Habecker,B.A.Infarct-derivedchondroitinsulfateproteoglycanspreventsympatheticreinnervationaftercardiacischemia-reperfusioninjury.J.Neurosci.33,7175–7183(2013).
24.Lorentz,C.U.etal.Sympatheticdenervationofperi-infarctmyocardiumrequiresthep75neurotrophinreceptor.Exp.Neurol.249,111–119(2013).25.Bai,R.etal.Ablationofventriculararrhythmiasinarrhythmogenicrightventriculardysplasia/cardiomyopathy:arrhythmia-freesurvivalafterendo-epicardialsubstratebasedmappingandablation.Circulation4,478–485(2011).
26.Lang,B.etal.SystemicmodulationoftheproteoglycanreceptorPTPspromotesfunctionalrecoveryafterspinalcordinjury.Nature;doi:10.1038/nature13974(2014).
27.Parrish,D.C.etal.Infarction-inducedcytokinescauselocaldepletionoftyrosinehydroxylaseincardiacsympatheticnerves.Exp.Physiol.95,304–314(2009).
28.Kimura,K.etal.Cardiacsympatheticrejuvenation:alinkbetweennervefunctionandcardiachypertrophy.Circ.Res.100,1755–1764(2007).
29.Shi,X.&Habecker,B.A.gp130cytokinesstimulateproteasomaldegradationoftyrosinehydroxylaseviaextracellularsignalregulatedkinases1and2.J.Neurochem.120,239–247(2012).
30.Dobaczewski,M.etal.Extracellularmatrixremodelingincanineandmousemyocardialinfarcts.CellTissueRes.324,475–488(2006).
31.Banville,I.&Gray,R.A.Effectofactionpotentialdurationandconductionvelocityrestitutionandtheirspatialdispersiononalternansandthestabilityofarrhythmias.J.Cardiovasc.Electrophysiol.13,1141–1149(2002).
32.Knollmann,B.C.,Schober,T.,Petersen,A.O.,Sirenko,S.G.&Franz,M.R.Actionpotentialcharacterizationinintactmouseheart:steady-statecyclelengthdependenceandelectricalrestitution.Am.J.Physiol.HeartCirc.Physiol.292,H614–H621(2007).
33.Lue,W.M.&Boyden,P.A.Abnormalelectricalpropertiesofmyocytesfromchronicallyinfarctedcanineheart.AlterationsinVmaxandthetransientoutwardcurrent.Circulation85,1175–1188(1992).
34.Bru-Mercier,G.etal.ExpressionofheartKþchannelsinadrenalectomizedandcatecholamine-depletedreserpine-treatedrats.J.Mol.CellCardiol.35,153–163(2003).
35.Muller,J.E.etal.Circadianvariationinthefrequencyofsuddencardiacdeath.Circulation75,131–138(1987).
36.Scheer,F.A.etal.Impactofthehumancircadiansystem,exercise,andtheirinteractiononcardiovascularfunction.Proc.NatlAcad.Sci.USA107,20541–20546(2010).
37.Wilson,L.D.,Wan,X.&Rosenbaum,D.S.Cellularalternans:amechanismlinkingcalciumcyclingproteinstocardiacarrhythmogenesis.Ann.N.Y.Acad.Sci.1080,216–234216-234(2006).
38.Myles,R.C.,Wang,L.,Kang,C.,Bers,D.M.&Ripplinger,C.M.Localbeta-adrenergicstimulationovercomessource-sinkmismatchtogeneratefocalarrhythmia.Circ.Res.110,1454–1464(2012).
39.Erickson,J.R.etal.DiabetichyperglycaemiaactivatesCaMKIIandarrhythmiasbyO-linkedglycosylation.Nature502,372–376(2013).
40.Vaseghi,M.etal.Cardiacsympatheticdenervationinpatientswithrefractoryventriculararrhythmiasorelectricalstorm:intermediateandlongtermfollowup.HeartRhythm11,6(2014).
41.Lopez-Sendon,J.etal.Expertconsensusdocumentonbeta-adrenergicreceptorblockers.Eur.HeartJ.25,1341–1362(2004).
42.Cao,J.M.etal.Nervesproutingandsuddencardiacdeath.Circ.Res.86,816–821(2000).
Acknowledgements
ThisworkwassupportedbyNHLBIHL093056andHL068231(B.A.H.)andHL111600(C.M.R.);NINDSNS25713(J.S.);theAmericanHeartAssociation12SDG9010015(C.M.R.);andanOregonBrainInstituteNeurobiologyofDiseaseFellowship(R.T.G.).WethankDrMichelTremblay(McGillUniversity,Montreal,Canada)forprovidingthePTPstransgenicmice.
Authorcontributions
R.T.G.,L.W.,C.M.R.andB.A.H.designedexperimentalapproachesandanalyseddata.R.T.G.performedallsurgicalproceduresanddruginjections.B.T.L.,J.C.andJ.S.designedanddevelopedtheintracellularsigmapeptide.R.T.G.andC.L.D.carriedoutimmunohistochemistry,quanti edinnervationdensityandinfarctsizeandanalysedECGrecordings.W.R.W,C.L.D.andR.T.G.collectedtissueandcarriedoutHPLCanalysisofNE.L.W.,C.M.R.andR.T.Gperformedandanalysedopticalmappingexperiments.Allauthorsdiscussedresultsandcommentedonthemanuscript.R.T.G.andB.A.H.wrotethemanuscript.
Additionalinformation
SupplementaryInformationaccompaniesthispaperatdoc.guandang.net
Competing nancialinterests:Theauthorsdeclarenocompeting nancialinterests.Reprintsandpermissioninformationisavailableonlineatdoc.guandang.net
Howtocitethisarticle:Gardner,R.T.etal.Targetingproteintyrosinephosphatasesaftermyocardialinfarctionrestorescardiacsympatheticinnervationandpreventsarrhythmias.Nat.Commun.6:6235doi:10.1038/ncomms7235(2015).
ThisworkislicensedunderaCreativeCommonsAttribution4.0InternationalLicense.Theimagesorotherthirdpartymaterialinthis
articleareincludedinthearticle’sCreativeCommonslicense,unlessindicatedotherwiseinthecreditline;ifthematerialisnotincludedundertheCreativeCommonslicense,userswillneedtoobtainpermissionfromthelicenseholdertoreproducethematerial.Toviewacopyofthislicense,visitdoc.guandang.net
NATURECOMMUNICATIONS|6:6235|DOI:10.1038/ncomms7235|doc.guandang.net
(泛素激活酶) + ATP AMP + ppi O Ubi—C—S—E1 E2—SH(泛素结合酶) E1—SH O Ubi—C—S--E2 O Ubi—C—S--E2 targeting protein (E3(泛素...
profiling has been exploited to identify miRNA genes that may represent downstream targets of activated oncogenic pathways or that are targeting protein-...
7.细胞生物学蛋白分选 protein sorting_英语学习_外语学习_教育专区。Protein targeting or protein sorting Road map of protein sorting Golgi ? 1972年,C....
Protein design approaches for potential therapeutic applications targeting protein-protein interactions are Received: September 9, 2012; Revised: September 17, ...
4.2 蛋白质分拣的基本原理蛋白质分拣(protein targeting):蛋白质分类并 转运到正确的细胞内部位的过程 蛋白质的正确分拣的条件: ? 一是蛋白质中包含特殊的信号...
蛋白质的靶向输送(protein targeting) 蛋白质合成后需要经过复杂机制,定向输送到最终发挥生物功能的细胞靶部位, 这一过程称为蛋白质的靶向输送。目录 ? 信号序列(...
-MSH Endophin 三、高级结构的修饰(一)亚基聚合 (二)辅基连接(三)疏水脂链的共价连接 四、蛋白质合成后的靶向输送蛋白质的靶向输送(protein targeting) 蛋白...
(三)疏水脂链的共价连接 四、蛋白质合成后的靶向输送蛋白质的靶向输送(protein targeting) 蛋白质合成后需要经过复杂机制,定 向输送到最终发挥生物功能的细胞靶部...
Targeting protein (目标蛋白): amino acid sequence; molecular weight; theoretical extinction coefficient at 280 nm; isoelectric point (pI); Literature search ...
和蛋白质靶向运输(protein targeting)错误!未找到引用源。 错误 未找到引用源。 胞外的蛋白质经胞吞作用进入细胞内部, 也经历分选和靶向运输过程。 细胞中每一种...
热门文档